These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21592522)

  • 1. State-dependent changes in the expression of DNA methyltransferases in mood disorder patients.
    Higuchi F; Uchida S; Yamagata H; Otsuki K; Hobara T; Abe N; Shibata T; Watanabe Y
    J Psychiatr Res; 2011 Oct; 45(10):1295-300. PubMed ID: 21592522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered sirtuin deacetylase gene expression in patients with a mood disorder.
    Abe N; Uchida S; Otsuki K; Hobara T; Yamagata H; Higuchi F; Shibata T; Watanabe Y
    J Psychiatr Res; 2011 Aug; 45(8):1106-12. PubMed ID: 21349544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant REST-mediated transcriptional regulation in major depressive disorder.
    Otsuki K; Uchida S; Wakabayashi Y; Matsubara T; Hobara T; Funato H; Watanabe Y
    J Psychiatr Res; 2010 Apr; 44(6):378-84. PubMed ID: 19846118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of splicing factor SRp20 mRNA in bipolar disorder patients.
    Watanuki T; Funato H; Uchida S; Matsubara T; Kobayashi A; Wakabayashi Y; Otsuki K; Nishida A; Watanabe Y
    J Affect Disord; 2008 Sep; 110(1-2):62-9. PubMed ID: 18281098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered gene expression of histone deacetylases in mood disorder patients.
    Hobara T; Uchida S; Otsuki K; Matsubara T; Funato H; Matsuo K; Suetsugi M; Watanabe Y
    J Psychiatr Res; 2010 Apr; 44(5):263-70. PubMed ID: 19767015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alteration of hypoxia inducible factor-1 (HIF-1) and its target genes in mood disorder patients.
    Shibata T; Yamagata H; Uchida S; Otsuki K; Hobara T; Higuchi F; Abe N; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():222-9. PubMed ID: 23333658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders.
    Wakabayashi Y; Uchida S; Funato H; Matsubara T; Watanuki T; Otsuki K; Fujimoto M; Nishida A; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1199-205. PubMed ID: 18430502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Glucocorticoid Receptor alpha Expression in Mood Disorder Patients and First-Degree Relatives.
    Matsubara T; Funato H; Kobayashi A; Nobumoto M; Watanabe Y
    Biol Psychiatry; 2006 Apr; 59(8):689-95. PubMed ID: 16458268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of glyoxalase-1 mRNA in mood disorder patients.
    Fujimoto M; Uchida S; Watanuki T; Wakabayashi Y; Otsuki K; Matsubara T; Suetsugi M; Funato H; Watanabe Y
    Neurosci Lett; 2008 Jun; 438(2):196-9. PubMed ID: 18455873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
    Girault I; Tozlu S; Lidereau R; Bièche I
    Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional biomarkers of mood disorders: differential diagnosis and clinical classification with gene expression in peripheral leukocytes].
    Watanabe Y; Uchida S; Otsuki K; Yamagata H; Hobara T; Abe N; Higuchi F; Watanuki T; Matsubara T
    Seishin Shinkeigaku Zasshi; 2012; 114(7):812-20. PubMed ID: 22897028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
    Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
    Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
    Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP
    Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus.
    Zhu X; Liang J; Li F; Yang Y; Xiang L; Xu J
    Int J Dermatol; 2011 Jun; 50(6):697-704. PubMed ID: 21595664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of expression and activity of DNA (cytosine-5) methyltransferases in mammalian cells.
    Kinney SR; Pradhan S
    Prog Mol Biol Transl Sci; 2011; 101():311-33. PubMed ID: 21507356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer.
    Kim H; Kwon YM; Kim JS; Han J; Shim YM; Park J; Kim DH
    Cancer; 2006 Sep; 107(5):1042-9. PubMed ID: 16888795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methyltransferase expression in the human endometrium: down-regulation by progesterone and estrogen.
    Yamagata Y; Asada H; Tamura I; Lee L; Maekawa R; Taniguchi K; Taketani T; Matsuoka A; Tamura H; Sugino N
    Hum Reprod; 2009 May; 24(5):1126-32. PubMed ID: 19202141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma.
    Park HJ; Yu E; Shim YH
    Cancer Lett; 2006 Feb; 233(2):271-8. PubMed ID: 15885882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
    Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
    Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.